Clinical Trials Directory

Trials / Unknown

UnknownNCT05508958

Cup Revisions Through Anterior or Posterolateral Approach: an RCT

Optimising Recovery After Cup Revision - is the Anterior Approach Superior to Posterolateral?

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
Reinier Haga Orthopedisch Centrum · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

With increasing numbers of total hip arthroplasties performed each year, the incidence of problems related to loosening and wear of total hip arthroplasties is expected to also increase. While the anterior approach for primary total hip arthroplasty has demonstrated to result in a faster short-term recovery than the traditional lateral and posterior approach, this effect has not yet been investigated in revision surgery. Accelerating functional outcome may increase patient satisfaction and reduce healthcare costs. The primary objective is to assess whether isolated cup revision surgery through the anterior approach results in increased functional status and higher patient satisfaction than through the posterolateral approach. This is a prospective Randomized Controlled Trial (RCT) in which 68 patients will be included (34 per group). Patients will be evaluated preoperatively and 6 weeks, 3 months and 1 year postoperatively. The main endpoints are functional recovery as measured with the 30-sec Chair Stand Test (30s-CST), 40m Fast Paced Walking Test (40m FPWT) and the Stair Climb Test (SCT). Secondary endpoints are Modified Borg scale outcomes after the functional tests, Numeric Rating Scale (NRS) for pain (rest/movement), Oxford Hip Score (OHS), HOOS-PS, EQ-5D-5L, satisfaction, cup inclination and complications at 30 days and 90 days postoperatively.

Conditions

Interventions

TypeNameDescription
PROCEDUREAnterior approachAnterior approach
PROCEDUREPosterolateral approachPosterolateral approach

Timeline

Start date
2022-09-08
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2022-08-19
Last updated
2022-09-13

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05508958. Inclusion in this directory is not an endorsement.